9th Annual Biomarkers Congress

Cancer Biology: Memorial Sloan-Kettering Cancer Center

Total Score People Score Events Score
148 106 75
Date Event Presentation Speakers
January 30, 2014 Genitourinary Cancers Symposium A Decade in Review: Prostate Cancer Peter T Scardino
Welcome and General Session 4: Multimodal Management of Urothelial Carcinoma (ARS) Hikmat Al-Ahmadie
October 27, 2013 Nature - CNIO Cancer Symposium: Frontiers in Tumour Heterogeneity and Plasticity Short Talk: “Serpins shield brain metastatic cells from death signals and vascular detachment” Manuel Valiente-Cortes
June 12, 2013 Montreal International Symposium on Angiogenesis and Metastasis – MISAM-2013 Montreal International Symposium on Angiogenesis and Metastasis – MISAM-2013 Eric C. Holland, Manuel Valiente-Cortes
April 6, 2013 AACR Annual Meetings CANCER EVOLUTION AND RESISTANCE Neal Rosen
Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom Hans-Guido Wendel
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY Jedd D. Wolchok, Margaret Callahan
Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Chris Sander
The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY Douglas A. Levine
Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO James P Allison
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James A. Fagin
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Clinical Trials Based on Mutations versus Histology Charles L Sawyers
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Neal Rosen
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX Andrea Ventura
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY David C Lyden
Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA Victoria M. Richon
Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY Johanna A. Joyce
March 21, 2013 The International Congress on Oncological Perspectives of Fertility Preservation: Gynecological & Breast Cancer (OP/FP) Cervix Cancer: Principles, Patient Selection, Surgical Techniques and Pregnancy Outcome Nadeem Abu-Rustum
Radical Abdominal Trachelectomy Nadeem Abu-Rustum
January 20, 2013 Tumor Invasion and Metastasis Macrophages as a therapeutic target in invasive gliomas Johanna A Joyce
Niches and pathways of latent and overt metastasis Joan Massagué
Session 4: Metastasis Signaling Pathways Joan Massagué
December 4, 2012 CGS – The Cancer Genome Summit Developing Genomic Signatures into Clinically Actionable Markers: Lessons from Glioblastoma Cameron W Brennan
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium Navigating the Obstacles and Risks of Survivorship – Ballroom A Michael L Krychman
The Practical Use of Molecular Profiling – Ballroom A Clifford Hudis
October 4, 2012 14th Annual Lynn Sage Breast Cancer Symposium Z11 One Year Later: Issues and Implementation Monica Morrow
Multidisciplinary Tumor Board: Case Reviews and Audience Response Monica Morrow
Radiation Alternatives in the Older Patient: Intraoperative, Short Course, PBI Alice Ho
Obesity, Inflammation and Breast Cancer Clifford Hudis
Optimizing Reconstructive Outcomes when PMRT is Necessary Babak Mehrara
September 13, 2012 International Society of Gastrointestinal Oncology Updates on Pathologic Classification and Grading of NETs David S. Klimstra
Chemotherapy and Radiation Therapy is Necessary Preoperative Therapy David H. Ilson
Session 1 | Esophageal/Gastric Cancer David H. Ilson
Welcome From the President David H. Ilson
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer Identifying Molecular Targets for the Treatment of Human Brain Cancer Eric C Holland
April 27, 2012 2012 Annual Paris Melanoma Conference An update on ipilimumab combination studies Jedd D. Wolchok
February 22, 2012 The SRS/SBRT Scientific Meeting - 2012 SBRT and Other Therapeutic Approaches for Clinically Localized Prostate Cancer Michael J Zelefsky
December 1, 2011 9th International Conference on Ovarian Cancer Secondary Surgical Cytoreduction Nadeem Abu-Rustum
Neoadjuvant Chemotherapy vs. Primary Surgical Cytoreduction Dennis S Chi
Hereditary Ovarian Cancer Noah D. Kauff
Closing Remarks and Adjourn Ginger J. Gardner
Video-Assisted Thorascopic Surgery (VATS) in Ovarian Cancer Yukio Sonoda
Robotics in the Modern Era of Ovarian Cancer Management Ginger J. Gardner
Ovarian Cancer Genomics: Impact on Prevention, Diagnosis, and Recurrence Douglas A. Levine
Consolidation Therapy in Ovarian Cancer Paul Sabbatini
Current Chemotherapy for Ovarian Cancer Carol Aghajanian
Session V | Novel Therapeutics Katherine M. Bell-McGuinn
November 15, 2011 Cosa 38th Annual Scientific Meeting Challenges in development of novel therapeutics Howard Scher
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Title to be announced Neal Rosen
Plenary Session 2 | Lessons from the BRAF-targeted Therapy of Melanoma Neal Rosen
Premetastatic niche | Opportunity for early intervention? David C Lyden
October 20, 2011 Nature Chemical Biology Symposium 2011: Cancer Chemical Biology TBA Neal Rosen
October 10, 2011 15th Annual Meeting Collaborative Group of the Americas, on Inherited Colorectal Cancer (CGA-ICC) Management of Rectal and Pouch Polyposis Jose Guillem
August 21, 2011 The TGF-β Superfamily: Signaling in Development and Disease A Smad epigenetic switch in stem cell regulation Joan Massagué
Session 9 | TGFβ signaling and Stem cell regulation Joan Massagué
June 30, 2011 2011 AHPBA Americas Post Graduate Course Advanced Interventional and Surgical Techniques to Improve Resectability for Patients with Hepatocellular Carcinoma Michael D’Angelica
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis The tumor microenvironment in cancer progression and response to therapy Johanna A Joyce
May 18, 2011 SBI 10th Postgraduate Course High Risk Screening D. David Dershaw
Challenging Cases MRI (Audience Response System) Christopher E. Comstock
Cancer | The Patient’s Perspective Laura Liberman
Management After MR Biopsy Carol H. Lee
Updates in Imaging | Cases for the Experts D. David Dershaw
March 27, 2011 Autophagy (D1) From ULK1 Complex-Mediated Autophagy Induction to Distinct Mechanism Governing Autophagosomal-Lysosomal Fusion Xuejun Jiang
March 9, 2011 28th Annual Miami Breast Cancer Conferenceâ„¢ Hereditary Breast Cancers Mark Robson
Occult Carcinoma Hiram S. Cody
Predisposition Syndromes Associated With Breast Cancer Mark Robson
How to Do a Sentinel Node Biopsy: Axillary Dissections and Internal Mammary Biopsy Hiram S. Cody
Sessions 3 | "Meet the Professor" Sessions Mark Robson
Session A | Prophylactic Contralateral Mastectomy: Current Recommendations, Technique, and Outcome Hiram S. Cody
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Priming the Soil: The Pre-Metastatic Niche David C Lyden
February 27, 2011 AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer Session 4 | Cancer Stem Cells/Developmental Biology Franziska Michor
February 24, 2011 Targeting P13K / mTOR Signaling in Cancer PI3K signaling and therapeutic response in gliomas Eric C Holland
Title to be announced Neal Rosen
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Overall Survival Andrew D. Zelenetz, MD, PhD
Welcome Andrew D. Zelenetz, MD, PhD
Do New Therapies Change the Paradigm for Treatment of Peripheral T-Cell Lymphoma? Steven Horwitz
Comment Steven Horwitz
Myeloproliferative Neoplasms Martin S. Tallman
Can Acute Promyelocytic Leukemia Be Managed Without Chemotherapy? Martin S. Tallman
Afternoon Workshop | Monoclonal Antibodies Andrew D. Zelenetz, MD, PhD
Supportive Care in Hematologic Malignancies Andrew D. Zelenetz, MD, PhD
Lymphoma Steven Horwitz
Chronic Lymphocytic Leukemia Andrew D. Zelenetz, MD, PhD
Tumor Boards | Challenging Cases in Hematologic Malignancies and Attendee-Submitted Cases Andrew David Zelenetz
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Challenges to clinical application of new discoveries in the genetics of breast cancer predisposition Mark Robson
The Clinical Utility of Genetic Testing for Inherited Predisposition to Breast Cancer: BRCA and Beyond | Ballroom C-2 Mark Robson
December 1, 2010 European Colorectal Congress 2010 Portal vein embolisation, neoadjuvant chemotherapy and surgery – treatment strategy for colorectal liver metastases D‘Angelica Michael
Video: Major hepatic resection for metastatic colorectal cancer Blumgart Leslie
ROUND TABLE LIVER METASTASES Blumgart Leslie
Regional chemotherapy for liver limited metastatic colorectal cancer Kemeny Nancy E Nancy
LIVER METASASES Blumgart Leslie
November 30, 2010 Tumor Immunology in Conjunction with the Cancer Immunology Working Group of the AACR Clinical and correlative immunologic results of CTLA-4 blockade in melanoma Jedd D. Wolchok
November 30, 2010 Tumor Immunology: Basic and Clinical Advances in Conjunction with the Cancer Immunology Working Group of the AACR Clinical and correlative immunologic results of CTLA-4 blockade in melanoma Jedd D. Wolchok
November 7, 2010 Frontiers of Immunology in Health and Diseases Frontiers of Immunology in Health and Diseases Eric Pamer
October 24, 2010 Frontiers in Tumour Progression Welcome Address and Keynote Lectures Joan Massagué
Two Short Talks Jacqueline F. Bromberg
Two Short Talks Johanna A Joyce
October 20, 2010 6th Annual Meeting of the Oligonucleotide Therapeutics Society Control of 3´UTR length by alternative cleavage and polyadenylation and its role in human cancer Christine Mayr
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR The pre-metastatic niche: Adapting the foreign soil David C Lyden
Plenary Session 1: The Influence of the Niche David C Lyden
Metastasis meets microenvironment Joan Massagué
Plenary Session 3: Novel Molecular Pathways Joan Massagué
July 11, 2010 Translational Cancer Medicine 2010 (USA) Predictors of RAS/RAF dependence David B. Solit
July 4, 2010 The Multiple Tiers of Gene Regulation in Cancer Translation Eric C Holland
June 24, 2010 The 1st International Congress on Longevity, Health and Aging (CoLONGY) DEBATE: Diabetes control in the elderly and the very elderly Patrick Boland
Session 4: Diabetes in elderly Patrick Boland
May 19, 2010 Towards Personalized Cancer Medicine Deconstructing Metastasis Joan Massagué
SESSION I: Biology (Processes Leading to Cancer) Joan Massagué
Closing Remarks Joan Massagué
Immune Checkpoint Blockade in Cancer Therapy James P Allison
December 11, 2009 Santa Fe Gastrointestinal Cancer Conference Clinical Presentation and Treatment of Biliary Tree Cancer Eileen M O'Reilly
Novel Treatments of HCC Ghassan Abou-Alfa
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Critical Review/Summary of Level of Evidence/Research Direction Simon Yeung
Session 3: Traditional Chinese Medicine Simon Yeung
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Panel Discussion With Interactive Q/A Leonard Saltz
Treatment of Incurable Metatstatic Colorectal Cancer Leonard Saltz
Panel Discussion With Interactive Q/A Nabil Rizk
Sparing Esophagus in Patients with Esophageal Cancer Nabil Rizk
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery Natural product-based libraries for chemical biology and drug discovery Derek Tan
July 5, 2009 Beatson Conference Keynote Speaker Joan Massagué
June 9, 2009 Translating Genomic Knowledge Chairperson’s Remarks Eric C Lai
Panel Discussion – Successful Data Flow in Translation Discovery Research Eric C Lai
February 7, 2009 Translation of the Cancer Genome SESSION 2: CONVERTING DATA INTO HYPOTHESES Cameron W Brennan
January 21, 2009 Advances in Prostate Cancer Research SESSION 4: TECHNOLOGIES / IMAGING Howard Scher
SESSION 7: THERAPEUTICS / IMMUNOTHERAPY James P Allison
January 12, 2009 Mouse Models of Cancer SESSION 5: INFLAMMATION AND MICROENVIRONMENT Johanna A Joyce
December 11, 2008 SAN ANTONIO BREAST CANCER SYMPOSIUM Deconstructing Metastasis Joan Massagué
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting Concurrent J: Merlin Blocks Tumorigenesis by Inhibiting a Nuclear E3 Ligase Filippo , Giancotti
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Split Session B: Integrative Oncology for Survivors: Complementary Therapies, Herbs and Other Non-Prescription Agents Barrie R. Cassileth
November 4, 2008 The Chemotherapy Foundation Symposium XXVI OR Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow EVEROLIMUS FOR RENAL CELL CARCINOMA Robert J. Motzer
USE OF METHADONE IN CANCER TREATMENT Nessa Coyle
VIDEO: CANCER THROUGH THE EYES OF THE PATIENT AND FAMILY Teresa Gilewski
October 22, 2008 HDAC Inhibitors: Targeting Oncology and Beyond Progress in the Development of Vorinostat Victoria M. Richon
October 21, 2008 20th EORTC - NCI - AACR Symposium on "Molecular Targets and Cancer Therapeutics" Plenary session 5 Molecular targets-state of the science C David M Spriggs
September 5, 2008 44th ASCO Annual Meeting General Session II: Angiogenesis and Insulin-like Growth Factor Receptor: New Targets in Breast Cancer Maura N Dickler
General Session V: Selected Controversies in Pathology Edi Brogi
General Session VI: Keynote: Self-Seeding Larry Norton, Joan Massagué
August 21, 2008 The Future of Cancer Diagnostics Molecular and Systems Pathology in the Diagnosis and Prognosis of Cancer Carlos Cordon Cardo
May 30, 2008 44th ASCO Annual Meeting Program Committee Harry Herr
May 30, 2008 ASCO Annual'08 Meeting general oncology sessions-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
general oncology sessions-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
breast cancer-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
central nervous system tumors-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
central nervous system tumors-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
clinical trials-- Patient-Reported Outcomes in Oncology Ethan M. Basch
gynecologic cancer-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
head and neck cancer-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
health services research-- Patient-Reported Outcomes in Oncology Ethan M. Basch
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
patient and survivor care-- Patient-Reported Outcomes in Oncology Ethan M. Basch
patient and survivor care-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
professional development-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
sarcoma/bone and soft tissue cancers-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
tumor biology-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
meet the professor sessions-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
February 19, 2008 Screening Europe Track A Novel High-Throughput Platforms Hakim Djaballah
Track A High Content Screening of Human ES Cells Using Laser Scanning Confocal Microscopy Hakim Djaballah
February 17, 2008 GRC - Glycolipid & Sphingolipid Biology Discussion Richard Kolesnick
February 11, 2008 Stem Cells World Congress High Content Screening of Human Embryonic Stem Cells: Implications in Novel Neurodegenerative and Cancer Therapies Hakim Djaballah
February 3, 2008 AACR - Cytoskeletal Signaling in Cancer PLENARY TALK Alan Hall
SESSION 3: MATRIX PROTEINS IN CANCER Filippo G. Giancotti
SESSION 4: HOT TOPICS: TALKS FROM ABSTRACTS Alan Hall
KEYNOTE ADDRESS Alan Hall
January 18, 2008 Translational Research Program Stem Cell Symposium RADIATION RESISTANCE/TARGETING STEM CELL PATHWAYS Dolores Hambardzumyan
December 1, 2007 47TH American Socieity of Cell Biology Getting In Shape: New Clues From the Fly Embryo Jennifer A Zallen
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. S. Larochelle, R P Fisher
The Cell Biology of Embryonic Patterning and Morphogenesis in the Mouse Embryo Kathryn V. Anderson, Josh Bloomekatz, Isabelle Migeotte
Binding of the HBV X Protein to hBubR1 Disturbs the Mitotic Checkpoint and Increases Chromosome Instability Jeff Lee
Polarized Cell Behavior during Axis Elongation in Drosophila. Jennifer A Zallen, J Blankenship, J S P. Sanny, O Weitz
November 15, 2007 2007 Fourth International Conference Introduction/Welcome Carol Aghajanian
1. Integrative Oncology Education Models Panel Gary E. Deng
1. Integrative Oncology Education Models Panel Gary E. Deng
The Patient’s Perspective Panel Carol Aghajanian
Poster Review Gary E. Deng
Tumor Board — Integrative Case Studies Carol Aghajanian
November 15, 2007 The Joint Meeting of the 4th ISC International Conference on Cancer Therapeutics and The 7th Princess Margaret Hospital Conference: New Developments in Cancer Management New targeted therapies in renal cell carcinoma Robert J. Motzer
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 6: New & Emerging Biomarkers & Drug Targets (09:00-12:00) Anh Tuan Phan
Session 6: G-quadruplex Structures of Nucleic Acids as Potential Targets for Drug Design (11:00-11:20) Anh Tuan Phan
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Concurrent Session 1: Clinical Pharmacogenetics: Assessing Global Diversity Eric C Lai
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) OVERCOMING THE CHALLENGES: ADVANCED HDAC INHIBITORS (08:30-11:10) Paul A. Marks
OVERCOMING THE CHALLENGES - ADVANCED HDAC INHIBITORS: Chairperson’s Remarks (08:30-08:40) Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Histone Deacetylase Inhibitors: Molecular Mechanism of Action (11:10-11:40) Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT(11:10-16:30) Howard Scher, Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Howard Scher, Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Chairperson’s Remarks (13:10-14:20) Paul A. Marks
October 1, 2007 Barcelona BioMed Conferences: STEM CELLS AND CANCER Session V: Cancer stem cells - II (09:15 - 12:20) Joan Massagué
Session V: Cancer stem cells - II (11:35 - 12:10) Joan Massagué
September 7, 2007 The 2007 Breast Symposium Non-Oncologic Consequences of Estrogen Depletion Michael L Krychman
Oral Abstract Presentation Session A 10:30 AM — 12:00 PM Larry Norton
General Session VI: HER2 Positive Breast Cancer 10:00 AM — 11:45 AM Clifford A. Hudis
Imaging and HER2 Therapy: Targeting and Response Steven M. Larson
August 11, 2007 Lipid signaling Pathways in Cancer Cooperative interaction of vascular and stem cell damage Richard Kolesnick
July 21, 2007 Hematopoietic Malignancies Insights into AML1-ETO gains-of-function Stephen Nimer
June 9, 2007 Mitosis: Spindle Assembly and Function kinase activity in positioning the RhoA-GTPase and triggering cytokinesis in human cells Prasad Jallepalli
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.